While oxytocin is the preferred first‐line uterotonic for PPH prevention and treatment, it requires cold‐chain transport and storage, as well as administration by an injection from a trained, skilled health worker—these requirements are not universally available in all settings where women give birth.9 The gene discussed is OXT; the disease is pulmonary arterial hypertension.